BFEC
TDOC icon

Benjamin F. Edwards & Company’s Teladoc Health TDOC Stock Holding History

Benjamin F. Edwards & Company’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$49K Buy
5,015
+3,396
+210% +$41.4K ﹤0.01% 1338
2024
Q1 		$24K Buy
1,619
+827
+104% +$15K ﹤0.01% 1484
2023
Q4 		$17K Buy
792
+640
+421% +$11.8K ﹤0.01% 1530
2023
Q3 		$3K Hold
152
– – ﹤0.01% 1644
2023
Q2 		$4K Hold
152
– – ﹤0.01% 1609
2023
Q1 		$4K Sell
152
-30
-16% -$803 ﹤0.01% 1610
2022
Q4 		$4K Sell
182
-47
-21% -$1.27K ﹤0.01% 1634
2022
Q3 		$6K Sell
229
-1,797
-89% -$63K ﹤0.01% 1528
2022
Q2 		$67K Sell
2,026
-3,159
-61% -$134K ﹤0.01% 972
2022
Q1 		$374K Buy
5,185
+1,188
+30% +$85.6K 0.02% 519
2021
Q4 		$367K Buy
3,997
+887
+29% +$106K 0.02% 526
2021
Q3 		$394K Buy
3,110
+1,282
+70% +$187K 0.02% 497
2021
Q2 		$304K Sell
1,828
-1,168
-39% -$189K 0.02% 555
2021
Q1 		$545K Sell
2,996
-171
-5% -$39.7K 0.03% 439
2020
Q4 		$633K Buy
3,167
+537
+20% +$109K 0.04% 386
2020
Q3 		$577K Buy
2,630
+33
+1% +$6.99K 0.04% 369
2020
Q2 		$496K Sell
2,597
-2,042
-44% -$358K 0.04% 369
2020
Q1 		$719K Sell
4,639
-812
-15% -$94.5K 0.06% 278
2019
Q4 		$456K Sell
5,451
-499
-8% -$38K 0.03% 405
2019
Q3 		$403K Buy
5,950
+1,421
+31% +$93.5K 0.03% 405
2019
Q2 		$301K Buy
4,529
+164
+4% +$9.56K 0.03% 451
2019
Q1 		$243K Sell
4,365
-42
-1% -$2.56K 0.02% 472
2018
Q4 		$218K Sell
4,407
-53
-1% -$3.24K 0.02% 472
2018
Q3 		$385K Sell
4,460
-5,379
-55% -$383K 0.04% 379
2018
Q2 		$571K Buy
9,839
+8,556
+667% +$418K 0.06% 301
2018
Q1 		$52K Buy
1,283
+1,083
+542% +$40.9K 0.01% 842
2017
Q4 		$7K Buy
+200
New +$6.64K ﹤0.01% 1294

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Benjamin F. Edwards & Company's TDOC Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Teladoc Health (TDOC) stake by 210% in Q2 2024, buying an estimated $41.4K and bringing the position to 5,015 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Benjamin F. Edwards & Company first reported a position in TDOC in Q4 2017 and has held it in 27 quarters since. The position peaked at $719K in Q1 2020. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Benjamin F. Edwards & Company held 5,015 shares of Teladoc Health worth $49K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 3,396 Teladoc Health shares in Q2 2024, an estimated $41.4K.
  • Teladoc Health made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1338 holding.
  • Benjamin F. Edwards & Company first reported a position in Teladoc Health in Q4 2017 and has held it in 27 quarters since.
  • Benjamin F. Edwards & Company's Teladoc Health position peaked at $719K in Q1 2020.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.